{"schemaVersion":"peptidescanner-evidence-bundle/v1","canonicalUrl":"https://peptidescanner.com/evidence/v1/peptides/histrelin.json","manifestUrl":"https://peptidescanner.com/evidence/v1/manifest.json","peptide":{"slug":"histrelin","name":"Histrelin","url":"https://peptidescanner.com/peptides/histrelin/"},"addressing":"objects is keyed by objectPathId. A URL fragment #<objectPathId> on this file names one evidence object. Every version of a record is placed in the bundle of the record's current first peptide.","objectCount":10,"objects":{"clinicaltrials-gov-nct00779103-histrelin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00779103-histrelin:v1","objectPathId":"clinicaltrials-gov-nct00779103-histrelin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00779103-histrelin/","json":"https://peptidescanner.com/evidence/v1/peptides/histrelin.json#clinicaltrials-gov-nct00779103-histrelin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/histrelin.md#clinicaltrials-gov-nct00779103-histrelin-v1"},"story":{"slug":"clinicaltrials-gov-nct00779103-histrelin","version":1,"domain":"Clinical trials","dateInSource":"2021-01-08","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["histrelin"],"peptides":[{"slug":"histrelin","url":"https://peptidescanner.com/peptides/histrelin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00779103","sourceIds":["ctg-observation-nct00779103-2021-01-08-94c632687e1b"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00779103 at 2026-11-16T01:35:22.086Z. Its registry update date was 2021-01-08, and PeptideScanner's reviewed identity mapping was histrelin.","sourceIds":["ctg-observation-nct00779103-2021-01-08-94c632687e1b"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00779103 at 2026-11-16T01:35:22.086Z. Its registry update date was 2021-01-08, and PeptideScanner's reviewed identity mapping was histrelin.","sourceIds":["ctg-observation-nct00779103-2021-01-08-94c632687e1b"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00779103-2021-01-08-94c632687e1b"]}],"sources":[{"id":"ctg-observation-nct00779103-2021-01-08-94c632687e1b","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00779103 · retained source version 2021-01-08:94c632687e1bf618ac93e922bb83d936319de6ff7a7775ebca2914188e136c14","url":"https://clinicaltrials.gov/study/NCT00779103"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"3a04d0c209eb2c65b0a3fcf66f42e56190127833f1d3710699d62f33e807e855","tierARecordSha256":"e6f7547cb3d7c0a234b6ccbef2bb6adec41434b197e13a0701e5443e53997f1c"},"integrity":{"algorithm":"sha256","contentSha256":"166583b445b011d3536ff7f7cca745941ed79fe0185e3a31b1601e186384bcfb"}},"fda-drugs-nda019836-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-drugs-nda019836:v1","objectPathId":"fda-drugs-nda019836-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-drugs-nda019836/","json":"https://peptidescanner.com/evidence/v1/peptides/histrelin.json#fda-drugs-nda019836-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/histrelin.md#fda-drugs-nda019836-v1"},"story":{"slug":"fda-drugs-nda019836","version":1,"domain":"Regulatory","dateInSource":"1991-12-24","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["histrelin"],"peptides":[{"slug":"histrelin","url":"https://peptidescanner.com/peptides/histrelin/"}]},"claims":[{"id":"headline","text":"Drugs@FDA application NDA019836","sourceIds":["fda-drugs-nda019836-1991-12-24-8b92e9e54bd4"]},{"id":"summary","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 019836 with status AP dated 1991-12-24, and names histrelin acetate among the application record's active ingredients.","sourceIds":["fda-drugs-nda019836-1991-12-24-8b92e9e54bd4"]},{"id":"paragraph-1","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 019836 with status AP dated 1991-12-24, and names histrelin acetate among the application record's active ingredients.","sourceIds":["fda-drugs-nda019836-1991-12-24-8b92e9e54bd4"]},{"id":"paragraph-2","text":"This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance.","sourceIds":["fda-drugs-nda019836-1991-12-24-8b92e9e54bd4"]}],"sources":[{"id":"fda-drugs-nda019836-1991-12-24-8b92e9e54bd4","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application NDA019836 · original submission status AP · 1991-12-24 · dataset 2026-11-13","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA019836%22&limit=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"333f8c29c7ba7e4d8e1bdff5789735d1c2ded98b83dbb22f3796aaf7f1036311","tierARecordSha256":"8b92e9e54bd40291957335a304cb294633f057b98d88b9fd8fa9e4005d92cd5f"},"integrity":{"algorithm":"sha256","contentSha256":"852b053eba50fcdd9934cb635d8eb2499aeea4d98cec14b87d4b52083381f03a"}},"fda-drugs-nda021732-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-drugs-nda021732:v1","objectPathId":"fda-drugs-nda021732-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-drugs-nda021732/","json":"https://peptidescanner.com/evidence/v1/peptides/histrelin.json#fda-drugs-nda021732-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/histrelin.md#fda-drugs-nda021732-v1"},"story":{"slug":"fda-drugs-nda021732","version":1,"domain":"Regulatory","dateInSource":"2004-10-12","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["histrelin"],"peptides":[{"slug":"histrelin","url":"https://peptidescanner.com/peptides/histrelin/"}]},"claims":[{"id":"headline","text":"Drugs@FDA application NDA021732","sourceIds":["fda-drugs-nda021732-2004-10-12-85afe307ada3"]},{"id":"summary","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 021732 with status AP dated 2004-10-12, and names histrelin acetate among the application record's active ingredients.","sourceIds":["fda-drugs-nda021732-2004-10-12-85afe307ada3"]},{"id":"paragraph-1","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 021732 with status AP dated 2004-10-12, and names histrelin acetate among the application record's active ingredients.","sourceIds":["fda-drugs-nda021732-2004-10-12-85afe307ada3"]},{"id":"paragraph-2","text":"This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance.","sourceIds":["fda-drugs-nda021732-2004-10-12-85afe307ada3"]}],"sources":[{"id":"fda-drugs-nda021732-2004-10-12-85afe307ada3","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application NDA021732 · original submission status AP · 2004-10-12 · dataset 2026-11-13","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA021732%22&limit=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"dc2f3ad56ab3ee34a0d5b1442c51c73e132386e288e0e80e790b4a57d81b85ea","tierARecordSha256":"85afe307ada3b565ce5d777bd42e6162e4a3cf69dff39498938d657663036b95"},"integrity":{"algorithm":"sha256","contentSha256":"d0645ad3109fb24c8aee3233547ee53f8c0739ed6fa00797a27d577d52bd1d11"}},"fda-drugs-nda022058-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-drugs-nda022058:v1","objectPathId":"fda-drugs-nda022058-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-drugs-nda022058/","json":"https://peptidescanner.com/evidence/v1/peptides/histrelin.json#fda-drugs-nda022058-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/histrelin.md#fda-drugs-nda022058-v1"},"story":{"slug":"fda-drugs-nda022058","version":1,"domain":"Regulatory","dateInSource":"2007-05-03","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["histrelin"],"peptides":[{"slug":"histrelin","url":"https://peptidescanner.com/peptides/histrelin/"}]},"claims":[{"id":"headline","text":"Drugs@FDA application NDA022058","sourceIds":["fda-drugs-nda022058-2007-05-03-5ff8727bd2ec"]},{"id":"summary","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 022058 with status AP dated 2007-05-03, and names histrelin acetate among the application record's active ingredients.","sourceIds":["fda-drugs-nda022058-2007-05-03-5ff8727bd2ec"]},{"id":"paragraph-1","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 022058 with status AP dated 2007-05-03, and names histrelin acetate among the application record's active ingredients.","sourceIds":["fda-drugs-nda022058-2007-05-03-5ff8727bd2ec"]},{"id":"paragraph-2","text":"This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance.","sourceIds":["fda-drugs-nda022058-2007-05-03-5ff8727bd2ec"]}],"sources":[{"id":"fda-drugs-nda022058-2007-05-03-5ff8727bd2ec","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application NDA022058 · original submission status AP · 2007-05-03 · dataset 2026-11-13","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA022058%22&limit=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"b7178630f518eaf9ecc5e24f3c8e7a332ad516578028b58c1121f71db2eab42e","tierARecordSha256":"5ff8727bd2ece10b7331b1db961d5a36deed620681f7e2a432bcd19881a6f922"},"integrity":{"algorithm":"sha256","contentSha256":"7c604a2a38b16eb225c16a1aff38fc18fb963304c32c2ea83a0f5ed5e0eeced7"}},"federal-register-03-20949-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:federal-register-03-20949:v1","objectPathId":"federal-register-03-20949-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/federal-register-03-20949/","json":"https://peptidescanner.com/evidence/v1/peptides/histrelin.json#federal-register-03-20949-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/histrelin.md#federal-register-03-20949-v1"},"story":{"slug":"federal-register-03-20949","version":1,"domain":"Regulatory","dateInSource":"2003-08-18","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["histrelin","secretin"],"peptides":[{"slug":"histrelin","url":"https://peptidescanner.com/peptides/histrelin/"},{"slug":"secretin","url":"https://peptidescanner.com/peptides/secretin/"}]},"claims":[{"id":"headline","text":"Federal Register notice 03-20949","sourceIds":["federal-register-03-20949-30e522866ea9"]},{"id":"summary","text":"The Federal Register published notice 03-20949, attributed to FDA and its parent HHS department, on 2003-08-18. Its official title is “Eli Lilly and Co. et al.; Withdrawal of Approval of 80 New Drug Applications and 75 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Histrelin and Secretin.","sourceIds":["federal-register-03-20949-30e522866ea9"]},{"id":"paragraph-1","text":"The Federal Register published notice 03-20949, attributed to FDA and its parent HHS department, on 2003-08-18. Its official title is “Eli Lilly and Co. et al.; Withdrawal of Approval of 80 New Drug Applications and 75 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Histrelin and Secretin.","sourceIds":["federal-register-03-20949-30e522866ea9"]},{"id":"paragraph-2","text":"This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use.","sourceIds":["federal-register-03-20949-30e522866ea9"]}],"sources":[{"id":"federal-register-03-20949-30e522866ea9","name":"Federal Register via GovInfo","sourceClass":"A","title":"Federal Register notice 03-20949 · published 2003-08-18 · Eli Lilly and Co. et al.; Withdrawal of Approval of 80 New Drug Applications and 75 Abbreviated New Drug Applications","url":"https://www.govinfo.gov/content/pkg/FR-2003-08-18/pdf/03-20949.pdf"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d739cac773b45208ae82e290d0ca589b0ce48f4ca51eda105e5bcb8dc059083d","tierARecordSha256":"30e522866ea9274956660af05c81ace9dfe71c401dc1ff8bbce487e2d7761437"},"integrity":{"algorithm":"sha256","contentSha256":"7c08fedd431dfbad95bccacc43bb888b0a2d5b2bb37ea047a5952ef9c2a4a5ef"}},"pubmed-pmid-19228148-histrelin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-19228148-histrelin:v1","objectPathId":"pubmed-pmid-19228148-histrelin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-19228148-histrelin/","json":"https://peptidescanner.com/evidence/v1/peptides/histrelin.json#pubmed-pmid-19228148-histrelin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/histrelin.md#pubmed-pmid-19228148-histrelin-v1"},"story":{"slug":"pubmed-pmid-19228148-histrelin","version":1,"domain":"Literature metadata","dateInSource":"2012-11-15","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["histrelin"],"peptides":[{"slug":"histrelin","url":"https://peptidescanner.com/peptides/histrelin/"}]},"claims":[{"id":"headline","text":"A review of the use of histrelin acetate in the treatment of prostate cancer.","sourceIds":["pubmed-observation-pmid-19228148-2012-11-15-9f9e6f88d18f"]},{"id":"summary","text":"PubMed lists PMID 19228148 in BJU international as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2009-03 (month precision). PeptideScanner associated the retained record with the identity slug histrelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19228148-2012-11-15-9f9e6f88d18f"]},{"id":"paragraph-1","text":"PubMed lists PMID 19228148 in BJU international as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2009-03 (month precision). PeptideScanner associated the retained record with the identity slug histrelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19228148-2012-11-15-9f9e6f88d18f"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-19228148-2012-11-15-9f9e6f88d18f"]}],"sources":[{"id":"pubmed-observation-pmid-19228148-2012-11-15-9f9e6f88d18f","name":"PubMed","sourceClass":"A","title":"A review of the use of histrelin acetate in the treatment of prostate cancer. · retained source version 1:2012-11-15:current:9f9e6f88d18fd227a203ad6f25e1e86f28402d4d36e82140e01970f777c543f2","url":"https://pubmed.ncbi.nlm.nih.gov/19228148/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"4178d025a2d340a2f5e54cdcacae97b4bad002e784b6d169c1017de8444799e4","tierARecordSha256":"7ab004ec1a5d77d0ad074ad00aa95eaf9bde12c4cdb8a6b90caabcd26a6fff43"},"integrity":{"algorithm":"sha256","contentSha256":"6e164d4ff95ef0b47d8204b83ba4ea904b72c52cc08da4a021052bb6cf9a6226"}},"pubmed-pmid-20329807-histrelin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-20329807-histrelin:v1","objectPathId":"pubmed-pmid-20329807-histrelin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-20329807-histrelin/","json":"https://peptidescanner.com/evidence/v1/peptides/histrelin.json#pubmed-pmid-20329807-histrelin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/histrelin.md#pubmed-pmid-20329807-histrelin-v1"},"story":{"slug":"pubmed-pmid-20329807-histrelin","version":1,"domain":"Literature metadata","dateInSource":"2021-10-20","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["histrelin"],"peptides":[{"slug":"histrelin","url":"https://peptidescanner.com/peptides/histrelin/"}]},"claims":[{"id":"headline","text":"Histrelin: in advanced prostate cancer.","sourceIds":["pubmed-observation-pmid-20329807-2021-10-20-8a4108973151"]},{"id":"summary","text":"PubMed lists PMID 20329807 in Drugs as Journal Article, Review, with publication-date metadata of 2010-03-26 (day precision). PeptideScanner associated the retained record with the identity slug histrelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20329807-2021-10-20-8a4108973151"]},{"id":"paragraph-1","text":"PubMed lists PMID 20329807 in Drugs as Journal Article, Review, with publication-date metadata of 2010-03-26 (day precision). PeptideScanner associated the retained record with the identity slug histrelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20329807-2021-10-20-8a4108973151"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-20329807-2021-10-20-8a4108973151"]}],"sources":[{"id":"pubmed-observation-pmid-20329807-2021-10-20-8a4108973151","name":"PubMed","sourceClass":"A","title":"Histrelin: in advanced prostate cancer. · retained source version 1:2021-10-20:current:8a41089731514dab539ad8962179088b8d996b2ae5606c92dec552b1afaea8ee","url":"https://pubmed.ncbi.nlm.nih.gov/20329807/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"78a0766f4bd32fb75b43aa9d0cb2828da8a1aec41f8244d8ecb429eae3d40ec6","tierARecordSha256":"4230da90d24b4904970ed33ee079665892b905f9253c98a7032cac2e7fa12ef4"},"integrity":{"algorithm":"sha256","contentSha256":"d9308c257ab4ecfc6aee02a4dd2dcf5d1bfc337b812e85c4135944313022a6d3"}},"pubmed-pmid-2051345-histrelin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-2051345-histrelin:v1","objectPathId":"pubmed-pmid-2051345-histrelin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-2051345-histrelin/","json":"https://peptidescanner.com/evidence/v1/peptides/histrelin.json#pubmed-pmid-2051345-histrelin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/histrelin.md#pubmed-pmid-2051345-histrelin-v1"},"story":{"slug":"pubmed-pmid-2051345-histrelin","version":1,"domain":"Literature metadata","dateInSource":"2019-07-10","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["histrelin"],"peptides":[{"slug":"histrelin","url":"https://peptidescanner.com/peptides/histrelin/"}]},"claims":[{"id":"headline","text":"Characterization of the solution degradation products of histrelin, a gonadotropin releasing hormone (LH/RH) agonist.","sourceIds":["pubmed-observation-pmid-2051345-2019-07-10-b4396c273f60"]},{"id":"summary","text":"PubMed lists PMID 2051345 in Journal of pharmaceutical sciences as Journal Article, with publication-date metadata of 1991-03 (month precision). PeptideScanner associated the retained record with the identity slug histrelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-2051345-2019-07-10-b4396c273f60"]},{"id":"paragraph-1","text":"PubMed lists PMID 2051345 in Journal of pharmaceutical sciences as Journal Article, with publication-date metadata of 1991-03 (month precision). PeptideScanner associated the retained record with the identity slug histrelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-2051345-2019-07-10-b4396c273f60"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-2051345-2019-07-10-b4396c273f60"]}],"sources":[{"id":"pubmed-observation-pmid-2051345-2019-07-10-b4396c273f60","name":"PubMed","sourceClass":"A","title":"Characterization of the solution degradation products of histrelin, a gonadotropin releasing hormone (LH/RH) agonist. · retained source version 1:2019-07-10:current:b4396c273f604fa65e817dd4c5b857f2a58f0e6d111b45d15611b1ca938f053c","url":"https://pubmed.ncbi.nlm.nih.gov/2051345/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"df53ec84bc8e17e93724e90f424e4890852c559950c53dbb7684449d29df3570","tierARecordSha256":"afee0f33b415161b9dbf1eb8d02ab44d2eccb88a34bd8f2f81b4df9a17ae6d47"},"integrity":{"algorithm":"sha256","contentSha256":"296a4718ab7dc75331b00a04b465439166941b809427180d8dba1da9d092bb8e"}},"pubmed-pmid-25899147-histrelin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-25899147-histrelin:v1","objectPathId":"pubmed-pmid-25899147-histrelin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-25899147-histrelin/","json":"https://peptidescanner.com/evidence/v1/peptides/histrelin.json#pubmed-pmid-25899147-histrelin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/histrelin.md#pubmed-pmid-25899147-histrelin-v1"},"story":{"slug":"pubmed-pmid-25899147-histrelin","version":1,"domain":"Literature metadata","dateInSource":"2026-01-28","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["histrelin"],"peptides":[{"slug":"histrelin","url":"https://peptidescanner.com/peptides/histrelin/"}]},"claims":[{"id":"headline","text":"Histrelin for central precocious puberty-a single surgeon experience.","sourceIds":["pubmed-observation-pmid-25899147-2026-01-28-644c4fbd7a06"]},{"id":"summary","text":"PubMed lists PMID 25899147 in The Journal of surgical research as Journal Article, with publication-date metadata of 2015-03-30 (day precision). PeptideScanner associated the retained record with the identity slug histrelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-25899147-2026-01-28-644c4fbd7a06"]},{"id":"paragraph-1","text":"PubMed lists PMID 25899147 in The Journal of surgical research as Journal Article, with publication-date metadata of 2015-03-30 (day precision). PeptideScanner associated the retained record with the identity slug histrelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-25899147-2026-01-28-644c4fbd7a06"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-25899147-2026-01-28-644c4fbd7a06"]}],"sources":[{"id":"pubmed-observation-pmid-25899147-2026-01-28-644c4fbd7a06","name":"PubMed","sourceClass":"A","title":"Histrelin for central precocious puberty-a single surgeon experience. · retained source version 1:2026-01-28:current:644c4fbd7a06a556ccb1bdf9c6aeb643e4768a1bf50a76d6419329213ca0f919","url":"https://pubmed.ncbi.nlm.nih.gov/25899147/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"7febce5e8f3e565a549c8f24dd2476edaeec902897ff888b0923c88eb9bc83c3","tierARecordSha256":"6a5af221ead8752952654466c99c677048e9e817132742a1fe3439a9c256dca6"},"integrity":{"algorithm":"sha256","contentSha256":"f13c1ca6d81e79ca960dfea41e8ac00f7d73e2cfa6b13cbad637d6f55ae437eb"}},"pubmed-pmid-7684676-histrelin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-7684676-histrelin:v1","objectPathId":"pubmed-pmid-7684676-histrelin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-7684676-histrelin/","json":"https://peptidescanner.com/evidence/v1/peptides/histrelin.json#pubmed-pmid-7684676-histrelin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/histrelin.md#pubmed-pmid-7684676-histrelin-v1"},"story":{"slug":"pubmed-pmid-7684676-histrelin","version":1,"domain":"Literature metadata","dateInSource":"2018-11-13","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["histrelin"],"peptides":[{"slug":"histrelin","url":"https://peptidescanner.com/peptides/histrelin/"}]},"claims":[{"id":"headline","text":"Histrelin. A review of its pharmacological properties and therapeutic role in central precocious puberty.","sourceIds":["pubmed-observation-pmid-7684676-2018-11-13-644d4fad787c"]},{"id":"summary","text":"PubMed lists PMID 7684676 in Drugs as Journal Article, Review, with publication-date metadata of 1993-04 (month precision). PeptideScanner associated the retained record with the identity slug histrelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-7684676-2018-11-13-644d4fad787c"]},{"id":"paragraph-1","text":"PubMed lists PMID 7684676 in Drugs as Journal Article, Review, with publication-date metadata of 1993-04 (month precision). PeptideScanner associated the retained record with the identity slug histrelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-7684676-2018-11-13-644d4fad787c"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-7684676-2018-11-13-644d4fad787c"]}],"sources":[{"id":"pubmed-observation-pmid-7684676-2018-11-13-644d4fad787c","name":"PubMed","sourceClass":"A","title":"Histrelin. A review of its pharmacological properties and therapeutic role in central precocious puberty. · retained source version 1:2018-11-13:current:644d4fad787c122d84735ecc39d838e4fc967b8429188d1be1356d0e323003f0","url":"https://pubmed.ncbi.nlm.nih.gov/7684676/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"4112559435e774e2e53f87585ef8b10437cb35acf958e75b54e2dab3f6c10226","tierARecordSha256":"940c760f8bc5a06c139ba2a99de903a167f40f4668a6739b1378a405c098778b"},"integrity":{"algorithm":"sha256","contentSha256":"3e4b06998b16d7662b318b53a84d4e320cd7f03e5da70ae70b71c4393b90f386"}}}}
